adenosine has been researched along with atenolol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Afridi, I; Moise, KJ; Rokey, R | 1 |
| Creek, RD; Katholi, RE; McCann, WP | 1 |
| DeWitt, DF; Sparks, HV; Wangler, RD | 1 |
| Gorman, MW; He, MX; Sparks, HV | 1 |
| Brooks, R; Collis, MG; Conant, AR; Pleeth, RM; Poucher, SM | 1 |
| Pearce, SH; Rees, CJ; Smith, RH | 1 |
| Borst, MM; Kübler, W; Marquetant, R; Strasser, RH | 1 |
| Casati, C; Forlani, A; Lozza, G; Monopoli, A | 1 |
| Alexander, SP; Hernández, F; Kendall, DA; Neil, KE | 1 |
| Channer, KS; Orme, S | 1 |
| Capecchi, PL; Colafati, M; Di Perri, T; Pasini, FL; Puccetti, L; Randisi, P | 1 |
| Dobson, JG; Fenton, RA; Monahan, TS; Sawmiller, DR | 1 |
| Anagnostopoulos, C; D'Souza, S; Reyes, E; Roughton, M; Stirrup, J; Underwood, SR | 1 |
| Cruzado-Quevedo, J; Hernandez-Cascales, J; Martinez-Sabater, H; Muñoz-Gimeno, L | 1 |
| Appelboam, A; Gagg, J; Morley-Smith, EJ | 1 |
1 review(s) available for adenosine and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for adenosine and atenolol
| Article | Year |
|---|---|
Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study.
Topics: Adenosine; Adrenergic beta-Antagonists; Aged; Atenolol; Blood Pressure; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Stenosis; Cross-Over Studies; Electrocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2010 |
20 other study(ies) available for adenosine and atenolol
| Article | Year |
|---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome.
Topics: Adenosine; Adult; Atenolol; Electrocardiography; Female; Heart Rate, Fetal; Humans; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1992 |
Endogenous intrarenal adenosine preserves renal blood flow in one-kidney, one clip rats.
Topics: Adenosine; Angiotensin II; Animals; Atenolol; Blood Pressure; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Renal Circulation; Saralasin; Theophylline; Vascular Resistance | 1988 |
Effect of beta-adrenergic blockade on nucleoside release from the hypoperfused isolated heart.
Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Guinea Pigs; Heart; Inosine; Male; Myocardium; Norepinephrine; Nucleosides; Oxygen Consumption; Perfusion; Propranolol; Regional Blood Flow; Time Factors | 1984 |
Adenosine formation during hypoxia in isolated hearts: effect of adrenergic blockade.
Topics: Adenosine; Animals; Atenolol; Guinea Pigs; Hypoxia; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Phenoxybenzamine; Phentolamine; Phosphates; Phosphorus | 1994 |
Myocardial infarction and purine transport inhibition in anaesthetised ferrets.
Topics: Adenosine; Animals; Atenolol; Blood Gas Analysis; Blood Pressure; Coronary Circulation; Ferrets; Heart Rate; Hemodynamics; Injections, Intravenous; Leukocyte Count; Male; Microspheres; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Thioinosine | 1994 |
Fetal monitoring during maternal antiarrhythmic therapy.
Topics: Adenosine; Adult; Atenolol; Cardiotocography; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Sotalol; Tachycardia, Supraventricular; Transposition of Great Vessels; Ultrasonography, Prenatal | 1993 |
Beta-blockade reduces effects of adenosine and carbachol by transregulation of inhibitory receptors and Gi proteins.
Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Atenolol; Carbachol; Cell Membrane; GTP-Binding Proteins; Heart; Homeostasis; In Vitro Techniques; Isoproterenol; Male; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Adrenergic, beta; Receptors, Muscarinic; Ventricular Function, Left | 1997 |
Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Felodipine; Hemodynamics; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Vasodilator Agents | 1997 |
Heterogeneity of beta-adrenoceptors in guinea-pig brain: radioligand binding and cyclic nucleotide generation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Cerebellum; Cyclic AMP; Cyclic GMP; Female; Guinea Pigs; Inositol Phosphates; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Male; Pindolol; Population; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Signal Transduction; Vasodilator Agents | 1997 |
Tachycardia following low-tension electrocution.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atenolol; Atrioventricular Node; Electric Injuries; Electrocardiography; Female; Humans; Tachycardia | 1999 |
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation.
Topics: Adenosine; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clonidine; Cold Temperature; Female; Heart Rate; Humans; Male; Norepinephrine; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Sympathetic Nervous System; Theophylline; Vasoconstriction; Vasodilator Agents | 1999 |
Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic beta-Antagonists; Animals; Atenolol; Drug Synergism; Heart; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Pertussis Toxin; Pressure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilation; Vasodilator Agents; Virulence Factors, Bordetella; Xanthines | 2000 |
Can adenosine cause asthma-like symptoms in patients with cardiac arrhythmias receiving atenolol?
Topics: Adenosine; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Bronchial Spasm; Female; Follow-Up Studies; Humans | 2012 |
Cardioversion of a supraventricular tachycardia (SVT) in a 7-year-old using a postural modification of the Valsalva manoeuvre.
Topics: Adenosine; Administration, Intravenous; Aftercare; Anti-Arrhythmia Agents; Atenolol; Child; Electric Countershock; Electrocardiography; Humans; Male; Posture; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Treatment Outcome; Valsalva Maneuver; Wolff-Parkinson-White Syndrome | 2017 |